Talis Biomedical Corporation announced that effective immediately Brian Coe has stepped down as CEO and will continue to work with the company as an advisor. The company also announced that Kim Popovits has been appointed as interim CEO and will lead the search efforts to hire the Company’s next President and CEO. Ms. Popovits is the former Chairman of the Board, President and Chief Executive Officer of Genomic Health. Ms. Popovits has been a member of the Board of Talis since 2020 and has stepped off in connection with her appointment as interim CEO in order for the Company to remain in compliance with requirements for Board independence.